In this pilot study, quetiapine was an effective augmenting agent in treatment-resistant depression.
No takes yet. Share an insight, caveat, or question.
Dorée et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: